Michigan Center for Pancreatic Cancer Molecular Diagnosis: The Serum Protein Microarray Project
- Identify specific proteins of interest to evaluate for their potential role as markers
for pancreatic cancer.
- Analyze serum proteins directly by mass spectrometry to identify new biomarkers of
pancreatic cancer that can be used for early diagnosis.
OUTLINE: Blood from patients is collected prior to treatment. Plasma proteins are analyzed
by matrix-assisted laser desorption ionization time-of-flight mass spectrometry
(MALDI-TOF/MS) and/or electrospray mass spectrometry (ESI/MS).
PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study.
Observational Model: Case-Only, Time Perspective: Prospective
Identification of specific proteins of interest to evaluate for their potential role as markers for pancreatic cancer
Upon collection when patient agrees to provide a one time venous blood collection
Basil El-Rayes, MD
Barbara Ann Karmanos Cancer Institute
United States: Federal Government
|Barbara Ann Karmanos Cancer Institute||Detroit, Michigan 48201|